A Novel Erinacine S Derivative from Hericium erinaceus Overcomes Chemoresistance in Colorectal Cancer Cells by Enhancing TRAIL/TNFR1/DR5 Expression through Histone Acetylation.

Hericium erinaceus

OncologyCognition & nerves

SpeciesLion's Mane, Yamabushitake

JournalInternational journal of medical sciences

Year2025

Metadata-grounded summary

Article summary

Metadata-grounded summary: This research article indexes research on Hericium erinaceus in International journal of medical sciences in 2025. MycoData maps the paper to oncology, cognition & nerves based on its title, species context, article metadata, and study classification.

Citation

Tung SY, Lee KF, Hsieh YY, Cheng KC, Lee KC, Lee LY, et al. (2025). A Novel Erinacine S Derivative from Hericium erinaceus Overcomes Chemoresistance in Colorectal Cancer Cells by Enhancing TRAIL/TNFR1/DR5 Expression through Histone Acetylation. International journal of medical sciences https://doi.org/10.7150/ijms.119894 PMID: 41209562

Open citation